These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6097091)

  • 41. Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.
    Watanabe M; Nagai M
    Infect Immun; 2001 Nov; 69(11):6981-6. PubMed ID: 11598073
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction of monoclonal antibodies with pertussis toxin and its subunits.
    Frank DW; Parker CD
    Infect Immun; 1984 Oct; 46(1):195-201. PubMed ID: 6207108
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Production and characterisation of monoclonal antibodies to outer-membrane-protein antigens of Vibrio cholerae O1.
    Kabir S
    J Med Microbiol; 1991 Mar; 34(3):167-73. PubMed ID: 1901361
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The specificity of antisera against Bordetella pertussis examined by bacterial agglutination.
    Fredriksen JH; Frøholm LO; Kjennerud U
    Acta Pathol Microbiol Immunol Scand B; 1987 Dec; 95(6):363-9. PubMed ID: 2894108
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular and functional analysis of the lipopolysaccharide biosynthesis locus wlb from Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica.
    Allen AG; Thomas RM; Cadisch JT; Maskell DJ
    Mol Microbiol; 1998 Jul; 29(1):27-38. PubMed ID: 9701800
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Suppression of serum antibody responses by pertussis toxin after respiratory tract colonization by Bordetella pertussis and identification of an immunodominant lipoprotein.
    Carbonetti NH; Artamonova GV; Andreasen C; Dudley E; Mays RM; Worthington ZE
    Infect Immun; 2004 Jun; 72(6):3350-8. PubMed ID: 15155640
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of Bordetella pertussis filamentous hemagglutinin-mediated cell adherence with monoclonal antibodies.
    Leininger E; Probst PG; Brennan MJ; Kenimer JG
    FEMS Microbiol Lett; 1993 Jan; 106(1):31-8. PubMed ID: 8440465
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Hybridomas synthesizing monoclonal antibodies to Bordetella pertussis toxins].
    Drobyshevskaia EI; Lapaeva IA; Spitsin SV; Gureeva AA; Amelina IP
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Oct; (10):8-12. PubMed ID: 3541466
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Variability in LPS composition, antigenicity and reactogenicity of phase variants of Bordetella pertussis.
    Ray A; Redhead K; Selkirk S; Poole S
    FEMS Microbiol Lett; 1991 Apr; 63(2-3):211-7. PubMed ID: 2060761
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The location of surface antigens of Bordetella pertussis by immuno-electron microscopy.
    Ashworth LA; Dowsett AB; Irons LI; Robinson A
    Dev Biol Stand; 1985; 61():143-51. PubMed ID: 2872100
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulation of Bordetella pertussis infection with monoclonal antibodies to pertussis toxin.
    Halperin SA; Issekutz TB; Kasina A
    J Infect Dis; 1991 Feb; 163(2):355-61. PubMed ID: 1703192
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human T cell immunity against Bordetella pertussis analyzed at clonal level.
    De Magistris MT; Rappuoli R; Tagliabue A
    Ann Ist Super Sanita; 1991; 27(1):33-6. PubMed ID: 1683526
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acquisition of IgG serum antibodies against two Bordetella antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussis.
    Isacson J; Trollfors B; Taranger J; Lagergård T
    Pediatr Infect Dis J; 1995 Jun; 14(6):517-21. PubMed ID: 7667057
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Importance of immunoelectrophoresis in agar and disc electrophoresis in polyacrylamide gel for characterizing different strains of Bordetella pertussis].
    Samsonova VS; Mamaeva EA; Bakulina NA; Efimova OG; Bevz NI
    Zh Mikrobiol Epidemiol Immunobiol; 1983 May; (5):47-50. PubMed ID: 6308926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell surface antigens of Bordetella pertussis.
    Parker CD; Branes LV; Armstrong SK; Frank DW; Cole A
    Dev Biol Stand; 1985; 61():123-36. PubMed ID: 2872098
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunity.
    Wolfe DN; Goebel EM; Bjornstad ON; Restif O; Harvill ET
    Infect Immun; 2007 Oct; 75(10):4972-9. PubMed ID: 17698566
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Specific and cross-reacting monoclonal antibodies to Bordetella parapertussis and Bordetella bronchiseptica lipopolysaccharides.
    Le Blay K; Caroff M; Richards JC; Perry MB; Chaby R
    Microbiology (Reading); 1994 Sep; 140 ( Pt 9)():2459-65. PubMed ID: 7524956
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tracheal colonization factor: a Bordetella pertussis secreted virulence determinant.
    Finn TM; Stevens LA
    Mol Microbiol; 1995 May; 16(4):625-34. PubMed ID: 7476158
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human T-cell immunity against Bordetella pertussis analyzed at clonal level.
    Tagliabue A; De Magistris MT; Rappuoli R
    Tokai J Exp Clin Med; 1988; 13 Suppl():253-7. PubMed ID: 2908527
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of monoclonal antibodies to serotype Bordetella pertussis isolates: comparison of results obtained by indirect whole-cell enzyme-linked immunosorbent assay and bacterial microagglutination methods.
    Tsang RS; Sill ML; Advani A; Xing D; Newland P; Hallander H
    J Clin Microbiol; 2005 May; 43(5):2449-51. PubMed ID: 15872280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.